
Join to View Full Profile
The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd., Unit 0426Houston, TX 77030
Dr. Willis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jason Willis is an oncologist in Houston, TX and is affiliated with multiple hospitals in the area, including University of Texas M.D. Anderson Cancer Center and Harris Health System. He received his medical degree from Weill Cornell Medicine and has been in practice 2 years. He specializes in cancer genetics/cancer risk assessment and gastrointestinal cancer and is experienced in pancreatic cancer.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
- Johns Hopkins UniversityResidency, Internal Medicine, 2014 - 2017
- Weill Cornell MedicineClass of 2014, M.D.
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2018 - 2026
- AL State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- TN State Medical License 2023 - 2025
- WA State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer Start of enrollment: 2019 Jul 22
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis.Michael G White, Reed I Ayabe, Mohammad A Zeineddine, Fadl A Zeineddine, Abdelrahman M G Yousef
Translational Oncology. 2025-05-01 - KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.Mahmoud Yousef, Abdelrahman Yousef, Mark W Hurd, Ashwathy Pillai, Saikat Chowdhury
Journal of Hematology & Oncology. 2025-04-17 - Mutational and co-mutational landscape of early onset colorectal cancer.Jumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G White
Biomarkers. 2025-02-01
Journal Articles
- Colorectal Premalignancy Is Associated with Consensus Molecular Subtypes 1 and 2L M Ellis, P M Lynch, J A Willis, S Kopetz, Annals of Oncology
Press Mentions
- AACR: MD Anderson Researchers Share Cancer BreakthroughsApril 22nd, 2025
- Breaking Barriers to Colorectal Cancer Care for Black PatientsNovember 7th, 2023
- ‘It’s Striking’: MD Anderson Researcher Investigates Cause of Racial Disparities in Colon CancerMarch 5th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: